X0306
4
2017-11-27
0001572552
Asterias Biotherapeutics, Inc.
AST
0001509725
Mulroy Michael H.
C/O ASTERIAS BIOTHERAPEUTICS, INC.
6300 DUMBARTON CIRCLE
FREMONT
CA
94555
true
true
President and CEO
Common Stock
2017-11-27
4
P
0
2076
2.41
A
5552
D
Stock Options (right to buy)
3.7
2027-06-26
Common Stock
800000
800000
D
The shares were purchased in multiple trades at prices ranging from $2.35 to $2.45. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
The shares of common stock reported herein were purchased via a 10b5-1 plan established by the Reporting Person on August 16, 2017, under which the Reporting Person is dedicating approximately 25 percent of his monthly after-tax salary to the purchase of Asterias common stock.
Subject to Mr. Mulroy's continued employment with the Company, the stock options vest in equal monthly installments over 48 months commencing on July 31, 2017. The stock options are exercisable upon vesting.
/s/ Michael H. Mulroy
2017-11-29